Article
Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting.
European journal of endocrinology - 1 Nov 2020
Thiele Susanne, Werner Ralf, Stubbe Annika, Hiort Olaf, Hoeppner Wolfgang
Abstract excerpt
BACKGROUND: Hypophosphataemic rickets (HR) comprise a clinically and genetically heterogeneous group of conditions, defined by renal-tubular phosphate wasting and consecutive loss of bone mineralisation. X-linked hypophosphataemia (XLH) is the most common form, caused by inactivating dominant mutations in PHEX, a gene encompassing 22 exons located at Xp22.1. XLH is treatable by anti-Fibroblast Growth Factor 23...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
